Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

This Article was originally published under Nature Research's License to Publish, but has now been made available under a CC BY-NC-ND license. The PDF and HTML versions of the Article have been modified accordingly.

Saved in:
Bibliographic Details
Published inThe American journal of gastroenterology Vol. 113; no. 12; p. 696
Main Authors Narula, Neeraj, Peerani, Farhad, Meserve, Joseph, Kochhar, Gursimran, Chaudrey, Khadija, Hartke, Justin, Chilukuri, Prianka, Koliani-Pace, Jenna, Winters, Adam, Katta, Leah, Shmidt, Eugenia, Hirten, Robert, Faleck, David, Parikh, Malav P, Whitehead, Diana, Boland, Brigid S, Singh, Siddharth, Sagi, Sashidhar Varma, Fischer, Monika, Chang, Shannon, Barocas, Morris, Luo, Michelle, Lasch, Karen, Bohm, Matthew, Lukin, Dana, Sultan, Keith, Swaminath, Arun, Hudesman, David, Gupta, Nitin, Shen, Bo, Kane, Sunanda, Loftus, Edward V, Siegel, Corey A, Sands, Bruce E, Colombel, Jean-Frederic, Sandborn, William J, Dulai, Parambir S
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer 01.04.2019
Online AccessGet full text

Cover

More Information
Summary:This Article was originally published under Nature Research's License to Publish, but has now been made available under a CC BY-NC-ND license. The PDF and HTML versions of the Article have been modified accordingly.
Bibliography:correction
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
ISSN:0002-9270
1572-0241
DOI:10.1038/s41395-018-0401-4